Gene: CRTAP
Official Full Name: cartilage associated proteinprovided by HGNC
Gene Summary: The protein encoded by this gene is similar to the chicken and mouse CRTAP genes. The encoded protein is a scaffolding protein that may influence the activity of at least one member of the cytohesin/ARNO family in response to specific cellular stimuli. Defects in this gene are associated with osteogenesis imperfecta, a connective tissue disorder characterized by bone fragility and low bone mass. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05938 | CRTAP Knockout cell line (HeLa) | Human | CRTAP | 1:3~1:6 | Negative | Online Inquiry |
KO05939 | CRTAP Knockout cell line (HCT 116) | Human | CRTAP | 1:2~1:4 | Negative | Online Inquiry |
KO05940 | CRTAP Knockout cell line (HEK293) | Human | CRTAP | 1:3~1:6 | Negative | Online Inquiry |
KO05941 | CRTAP Knockout cell line (A549) | Human | CRTAP | 1:3~1:4 | Negative | Online Inquiry |
CRTAP Gene Knockout Cell Lines are genetically engineered cell cultures specifically designed to lack the CRTAP (Collagen prolyl 4-hydroxylase, protein A) gene. This product provides researchers with a powerful tool to investigate the biological roles of CRTAP, particularly its involvement in collagen synthesis and bone development. The targeted deletion of the CRTAP gene facilitates detailed studies into the molecular mechanisms underlying connective tissue disorders, such as osteogenesis imperfecta and other skeletal dysplasias.
The unique functionality of CRTAP Gene Knockout Cell Lines arises from their ability to mimic genetic conditions that alter collagen structure, thereby serving as an invaluable model for both in vitro and in vivo studies. Researchers can explore the effects of CRTAP deficiency on cell proliferation, differentiation, and extracellular matrix formation, shedding light on pathological processes that can lead to serious clinical implications. Moreover, these cell lines are crucial for drug discovery and development, allowing for high-throughput screening of potential therapeutics aimed at restoring normal collagen formation or mitigating the effects of CRTAP loss.
One of the key advantages of our CRTAP Gene Knockout Cell Lines is the precision of the gene editing technique employed, ensuring a reliable model with consistent expression profiles. Compared to other available models such as CRISPR-Cas9 edited cell lines, our product features enhanced stability and reproducibility, reducing variability in experimental outcomes. This robustness makes our cell lines particularly suitable for long-term studies and applications requiring precise gene manipulation.
As a leading provider of biological research tools, our company specializes in the development of high-quality cell lines that cater to the needs of both academic and industrial researchers. With a commitment to rigorous quality controls and comprehensive technical support, we empower scientists to advance their research in the understanding and treatment of collagen-related disorders. Choosing CRTAP Gene Knockout Cell Lines not only elevates your research capabilities but also contributes to the broader discovery of innovative solutions in the field of regenerative medicine and genetic therapies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.